INmune Bio Inc. has announced that it will hold a Special Meeting of Stockholders virtually. During the meeting, shareholders will vote on two key proposals: the approval of the repricing of certain outstanding stock options, and the approval of an adjournment of the Special Meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-096059), on October 03, 2025, and is solely responsible for the information contained therein.